Methazolamide
- Generic Name
- Methazolamide
- Drug Type
- Small Molecule
- Chemical Formula
- C5H8N4O3S2
- CAS Number
- 554-57-4
- Unique Ingredient Identifier
- W733B0S9SD
Overview
A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
Background
A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
Indication
For treatment of chronic open-angle glaucoma and acute angle-closure glaucoma
Associated Conditions
- Acute angle-closure glaucoma
- Open Angle Glaucoma (OAG)
Clinical Trials
FDA Approved Products
methazolamide
Manufacturer:Effcon Laboratories, Inc.
Route:ORAL
Strength:50 mg in 1 1
Approved: 2024/01/09
NDC:55806-020
Methazolamide
Manufacturer:ANI Pharmaceuticals, Inc.
Route:ORAL
Strength:50 mg in 1 1
Approved: 2017/05/12
NDC:62559-241
Methazolamide
Manufacturer:TAGI Pharma, Inc.
Route:ORAL
Strength:50 mg in 1 1
Approved: 2023/03/23
NDC:51224-124
Methazolamide
Manufacturer:Oceanside Pharmaceuticals
Route:ORAL
Strength:25 mg in 1 1
Approved: 2020/04/01
NDC:68682-022
Methazolamide
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:50 mg in 1 1
Approved: 2017/05/12
NDC:63629-1987
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath